Literature DB >> 7358841

In vitro defects of phagocyte chemotaxis during pregnancy.

M C Maltzer, J Silva.   

Abstract

Pregnant women have an increased risk for some infections, particularly during the last trimester. Phagocytic emigration from the circulation into tissues is an important aspect of the initial immune response. Therefore, circulating phagocytes of 42 pregnant and 15 postpartum patients were studied in vitro for random and chemotactic (or directional) migration through membrane filters (Millipore Corp., Bedford, Mass.). Random migration of phagocytes from all 42 pregnant patients studied in each trimester was within normal limits. Chemotactic migration of 25 patients who were between 6 and 33 weeks of pregnancy was also similar to values obtained with control leukocytes (20 nonpregnant, normal females. However, phagocytes of 17 other women studied between week 34 of pregnancy and term showed marked depressions in chemotaxis (P less than 0.001 from control values). During labor and within 3 days of delivery, chemotactic migration increased to supranormal levels in 14 of 15 women studied. Sera from six pregnant patients with proven chemotactic defects did not reduce migration when incubated with normal phagocytes. These chemotactic defects appear to be intrinsic and may be important in predisposing to infections during late pregnancy.

Entities:  

Mesh:

Year:  1980        PMID: 7358841      PMCID: PMC273347          DOI: 10.1128/jcm.11.2.170-173.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  THE ROLE OF THE PHAGOCYTE IN HOST-PARASITE INTERACTIONS. II. THE PHAGOCYTIC CAPABILITIES OF LEUKOCYTES IN PREGNANT WOMEN.

Authors:  G W MITCHELL; A J SBARRA
Journal:  Am J Obstet Gynecol       Date:  1965-03-15       Impact factor: 8.661

2.  Immune responses in pregnancy.

Authors:  J K Smith; E A Caspary; E J Field
Journal:  Lancet       Date:  1972-01-08       Impact factor: 79.321

3.  Anti-inflammatory effects of estradiol on human blood leukocytes.

Authors:  P Bodel; G M Dillard; S S Kaplan; S E Malawista
Journal:  J Lab Clin Med       Date:  1972-09

4.  Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.

Authors:  Y H Thong; R W Steele; M M Vincent; S A Hensen; J A Bellanti
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

5.  Effect of pregnancy serum on experimental inflammation.

Authors:  R H Persellin; S E Vance; A Peery
Journal:  Br J Exp Pathol       Date:  1974-02

6.  Energy metabolism and protein synthesis in human leukocytes during pregnancy and in placenta related to fetal growth.

Authors:  J Metcoff; J Wikman-Coffelt; T Yoshida; A Bernal; A Rosado; P Yoshida; J Urrusti; S Frenk; R Madrazo; L Velasco; M Morales
Journal:  Pediatrics       Date:  1973-05       Impact factor: 7.124

7.  Long-term (10 to 14 years) follow-up of bacteriuria of pregnancy.

Authors:  S H Zinner; E H Kass
Journal:  N Engl J Med       Date:  1971-10-07       Impact factor: 91.245

8.  Chemotaxis of human leukocytes: responsiveness to Mycoplasma pneumoniae.

Authors:  R R Martin; G Warr; R Couch; V Knight
Journal:  J Lab Clin Med       Date:  1973-04

9.  Impairment of immunity during pregnancy and antiviral effect of amniotic fluid.

Authors:  A S Pacsa
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321

10.  Specific leukocyte receptors for small endogenous hormones. Detection by cell binding to insolubilized hormone preparations.

Authors:  Y Weinstein; K L Melmon; H R Bourne; M Sela
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

View more
  2 in total

1.  Pasteurella multocida septicemia during pregnancy.

Authors:  B Rasaiah; J G Otero; I J Russell; D A Butler-Jones; J F Prescott; M M West; B E Maxwell; J Beaver
Journal:  CMAJ       Date:  1986-12-15       Impact factor: 8.262

2.  Human sex hormones stimulate the growth and maturation of Coccidioides immitis.

Authors:  D J Drutz; M Huppert; S H Sun; W L McGuire
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.